$46.9 Million is the total value of Morgenthaler Management Partners IX, LLC's 2 reported holdings in Q1 2019. The portfolio turnover from Q4 2018 to Q1 2019 was 33.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| RARX | Sell | Ra Pharmaceuticals, Inc. | $27,547,000 | -39.4% | 1,229,782 | -50.8% | 58.79% | +61.9% |
| VAPO | Vapotherm, Inc. | $19,310,000 | -1.5% | 982,690 | 0.0% | 41.21% | +163.1% | |
| PRNB | Exit | Principia Biopharma, Inc. | $0 | – | -2,195,125 | -100.0% | -48.03% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-05-15
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Calithera Biosciences, Inc. | 4 | Q3 2016 | 100.0% |
| Vapotherm, Inc. | 3 | Q2 2019 | 100.0% |
| LendingClub Corporation | 2 | Q1 2016 | 60.1% |
| Ra Pharmaceuticals, Inc. | 2 | Q1 2019 | 58.8% |
| Amicus Therapeutics, Inc. | 2 | Q1 2016 | 22.0% |
| Principia Biopharma, Inc. | 1 | Q4 2018 | 48.0% |
| salesforce.com, inc. | 1 | Q4 2015 | 3.4% |
| 0 | 1 | Q4 2021 | 0.0% |
View Morgenthaler Management Partners IX, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2022-02-11 |
| 4 | 2021-11-12 |
| 4 | 2021-06-28 |
| 3 | 2021-06-23 |
| 13F-HR | 2019-08-14 |
| 13F-HR | 2019-05-15 |
| 13F-HR | 2019-02-14 |
| 4 | 2018-11-20 |
| 3 | 2018-11-13 |
| 3 | 2018-09-13 |
View Morgenthaler Management Partners IX, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.